{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T18:10:14Z","timestamp":1722276614800},"reference-count":5,"publisher":"American Psychiatric Association Publishing","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AJP"],"published-print":{"date-parts":[[2004,4,1]]},"DOI":"10.1176\/appi.ajp.161.4.756","type":"journal-article","created":{"date-parts":[[2004,3,31]],"date-time":"2004-03-31T22:42:58Z","timestamp":1080772978000},"page":"756-756","source":"Crossref","is-referenced-by-count":6,"title":["Alendronic Acid for Antipsychotic-Related Osteopenia"],"prefix":"10.1176","volume":"161","author":[{"given":"OLIVER","family":"HOWES","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SHUBULADE","family":"SMITH","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"230","reference":[{"key":"R1614BCFFDBGI","doi-asserted-by":"crossref","unstructured":"Colao A, di Somma C, Loche S, di Sarno A, Klain M, Pivonello R, Pietrosante M, Salvatore M, Lombardi G: Prolactinomas in adolescents: persistent bone loss after 2 years of prolactin normalization. Clin Endocrinol (Oxf) 2000; 52:319\u2013327","DOI":"10.1046\/j.1365-2265.2000.00902.x"},{"key":"R1614BCFBDEAD","doi-asserted-by":"crossref","unstructured":"Smith S, Wheeler MJ, Murray R, O\u2019Keane V: The effects of antipsychotic-induced hyperprolactinaemia on the hypothalamic-pituitary-gonadal axis. J Clin Psychopharmacol 2002; 22:109\u2013114","DOI":"10.1097\/00004714-200204000-00002"},{"key":"R1614BCFBFFAF","unstructured":"Hodgson SF, Watts NB, Bilezikian JP, Clarke BL, Gray TK, Harris DW, Johnston CC, Kleerekoper M, Lindsay R, Luckey MM, McClung MR, Nankin HR, Petak SM, Recker RR: American Association of Clinical Endocrinologists 2001 medical guidelines for clinical practice for the prevention and management of postmenopausal osteoporosis. Endocr Pract 2001; 7:293\u2013312"},{"key":"R1614BCFBCHJG","doi-asserted-by":"crossref","unstructured":"Canuso CM, Goldstein JM, Wojcik J, Dawson R, Brandman D, Klibanski A, Schildkraut JJ, Green AI: Antipsychotic medication, prolactin elevation, and ovarian function in women with schizophrenia and schizoaffective disorder. Psychiatry Res 2002; 111:11\u201320","DOI":"10.1016\/S0165-1781(02)00123-3"},{"key":"R1614BCFJCDJJ","doi-asserted-by":"crossref","unstructured":"Goodnick PJ, Rodriguez L, Santana O: Antipsychotics: impact on prolactin levels. Expert Opin Pharmacother 2002; 3:1381\u20131391","DOI":"10.1517\/14656566.3.10.1381"}],"container-title":["American Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/psychiatryonline.org\/doi\/10.1176\/appi.ajp.161.4.756","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T17:36:11Z","timestamp":1722274571000},"score":1,"resource":{"primary":{"URL":"https:\/\/psychiatryonline.org\/doi\/10.1176\/appi.ajp.161.4.756"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4,1]]},"references-count":5,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,4,1]]}},"alternative-id":["10.1176\/appi.ajp.161.4.756"],"URL":"https:\/\/doi.org\/10.1176\/appi.ajp.161.4.756","relation":{},"ISSN":["0002-953X","1535-7228"],"issn-type":[{"type":"print","value":"0002-953X"},{"type":"electronic","value":"1535-7228"}],"subject":[],"published":{"date-parts":[[2004,4,1]]}}}